Werewolf Therapeutics

Werewolf Therapeutics FCF per Share

The Free Cash Flow per Share of Werewolf Therapeutics (HOWL) as of Oct 31, 2026 is -1.29 USD. In the previous year, Free Cash Flow per Share was -1.27 USD — a change of 1.50% (lower).

FCF per Share

-1.29USD

YoY

1.50%

Last updated:

Free Cash Flow per Share of Werewolf Therapeutics is 2025 -1.29 USD. Free Cash Flow per Share of Werewolf Therapeutics was 2024 -1.27 USD. It decreases by 1.50% lower compared to the previous year.

The Werewolf Therapeutics FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2019
-9.81 USD
Jan 1, 2020
-2.14 USD
Jan 1, 2021
-1.59 USD
Jan 1, 2022
-1.44 USD
Jan 1, 2023
-0.91 USD
Jan 1, 2024
-1.27 USD
Jan 1, 2025
-1.29 USD
The Werewolf Therapeutics FCF per Share history
YEARFCF per ShareYoY
-1.29USD+1.50%
-1.27USD+39.02%
-0.91USD-36.54%
-1.44USD-9.57%
-1.59USD-25.62%
-2.14USD-78.20%
-9.81USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Werewolf Therapeutics Stock analysis

What does Werewolf Therapeutics do? Werewolf Therapeutics Inc, based in Watertown, Massachusetts, is a biopharmaceutical company operating in the Health Care sector. The company focuses on developing therapeutics that stimulate the immune system to treat cancer, utilizing its PREDATOR platform to create conditionally activated molecules. With 46 employees, it is advancing clinical-stage candidates WTX-124 and WTX-330, systemically delivered IL-2 and IL-12 INDUKINE molecules designed to selectively activate in the tumor microenvironment for solid tumor treatment. Werewolf Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Werewolf Therapeutics stock

Free Cash Flow per Share of Werewolf Therapeutics is -1.29 USD in 2025.

Free Cash Flow per Share of Werewolf Therapeutics changed from -1.27 USD to -1.29 USD, representing a 1.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Werewolf Therapeutics since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Werewolf Therapeutics

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Werewolf Therapeutics